GMP facility will be built on Vesta’s premises.

Cytonet and Vesta Therapeutics signed a mutual strategic collaboration agreement that involves the construction of a GMP facility, in accordance with European standards, on the premises of Vesta Therapeutics in Durham, NC. Liver cell products for Cytonet’s clinical trials will be produced at the facility in the future.

Cytonet says it has managed to refine techniques of cell isolation and processing to the extent that human liver cells can be obtained in medicinal product quality in a routine production process. The goal is to treat various liver disease.

Previous articleInvitrogen Partners with Wave Biotech, LLC
Next articleTrellis Bioscience and PDL BioPharma Partner to Discover Novel Antibodies